Active, Not Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
NCT03958877
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- UC San Diego Health La Jolla, California, United States
- UNC Hospitals Chapel Hill, North Carolina, United States
- Meridian Clinical Research Norfolk, Virginia, United States
- Hospital Italiano de Buenos Aires Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina